Influenza Hemagglutinin (HA) Peptide: Molecular Tag for Precision Protein Detection and Purification

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a nine-amino acid synthetic tag derived from the human influenza virus and is widely used in molecular biology for protein detection, purification, and interaction studies [APExBIO]. It displays high solubility (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water) and is supplied at >98% purity, confirmed by HPLC and mass spectrometry. The HA tag enables competitive elution of HA-tagged fusion proteins by binding anti-HA antibodies, streamlining immunoprecipitation workflows (Dong et al., 2025). Proper storage at -20°C, desiccated, is required for peptide stability. Its utility is supported by extensive benchmarking and cross-study reproducibility [Flag-Peptide.com].

Biological Rationale

The HA tag is derived from the influenza virus hemagglutinin protein, a viral surface glycoprotein involved in host cell entry (Dong et al., 2025). The YPYDVPDYA sequence represents a minimal epitope recognized with high specificity by anti-HA monoclonal antibodies. Fusion of this tag to recombinant proteins enables their selective detection, isolation, and study without altering native protein structure or function [Inca-6.com]. Such epitope tagging systems are fundamental for workflows requiring precise protein quantification, mapping of protein-protein interactions, and immunoprecipitation with minimal background. The HA tag is especially valuable because it is not natively present in most studied organisms, minimizing off-target binding.

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The Influenza Hemagglutinin (HA) Peptide acts as a competitive inhibitor in immunoaffinity-based workflows [APExBIO]. When introduced into an immunoprecipitation or affinity purification assay, the free peptide binds to anti-HA antibodies, displacing HA-tagged fusion proteins from antibody-bound matrices such as magnetic beads. This mechanism allows for the gentle elution of target proteins under physiological conditions, preserving native interactions and activity [Cy5-5-NHS-Ester.com]. The HA tag sequence (YPYDVPDYA) is short and hydrophilic, minimizing steric hindrance and maximizing accessibility when fused to different termini of recombinant proteins. The specificity of the interaction is dictated by the unique epitope-antibody recognition, ensuring robust selectivity in complex biological samples.

Evidence & Benchmarks

• The HA peptide enables specific elution of HA-tagged fusion proteins in immunoprecipitation workflows, as demonstrated using anti-HA magnetic beads (Dong et al., 2025, https://doi.org/10.1002/advs.202504704).
• Solubility values of the peptide are ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water, supporting versatility across buffer systems (APExBIO).
• Purity exceeds 98%, validated by HPLC and mass spectrometry, minimizing contamination or batch-to-batch variability (APExBIO).
• HA tag sequence (YPYDVPDYA) is confirmed as a non-immunogenic, high-affinity epitope for monoclonal antibody recognition (Flag-Peptide.com).
• Benchmarking studies show robust performance in protein-protein interaction studies and competitive binding assays (Perylene-Azide.com).

Applications, Limits & Misconceptions

The HA tag peptide is applied in:

• Immunoprecipitation and co-immunoprecipitation to isolate HA-tagged proteins.
• Protein purification workflows under native or denaturing conditions.
• Protein-protein interaction mapping using competitive elution strategies.
• Quantitative detection of recombinant proteins by Western blot, ELISA, or immunofluorescence.
• Translational research, including analysis of ubiquitin signaling and metastasis inhibition (Dong et al., 2025).

Compared to previous reviews which focus on general detection in translational research, this article provides updated solubility parameters and precision workflow integration advice.

Common Pitfalls or Misconceptions

• Not all anti-HA antibodies recognize all HA tag fusions; antibody validation is required for each system.
• Excess peptide in elution buffers can interfere with downstream mass spectrometry or functional assays.
• The HA peptide cannot be used as an affinity tag for direct immobilization on most chromatography matrices.
• Long-term storage of diluted peptide solutions can lead to degradation; always prepare fresh working solutions.
• HA tag may not be suitable for proteins with large N- or C-terminal extensions that mask epitope accessibility.

Workflow Integration & Parameters

The Influenza Hemagglutinin (HA) Peptide (SKU: A6004, APExBIO) is supplied as a lyophilized powder at >98% purity. For optimal results:

• Reconstitute at ≥1 mg/mL in DMSO, ethanol, or water depending on the assay compatibility.
• Store desiccated at -20°C; avoid repeated freeze-thaw cycles.
• For immunoprecipitation, typical working concentrations range from 0.5–2 mg/mL; titration is recommended.
• Use only freshly prepared working solutions to maintain peptide integrity.
• Validate peptide concentration and antibody compatibility for each new assay or protein of interest.

This article updates and extends the troubleshooting guidelines presented in GTP-Binding-Protein-Fragment-G-Alpha.com by providing experimentally confirmed solubility and usage parameters for high-purity preparations.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide is a validated and highly reproducible epitope tag for molecular biology and biochemistry. Its small size, specificity, and compatibility with gentle elution techniques make it indispensable for precision protein detection and purification. As workflows evolve to include more complex interaction networks and high-throughput proteomics, the HA tag remains a gold-standard molecular tool. For detailed protocols and advanced applications, refer to the A6004 product page and consult benchmarking articles for troubleshooting and optimization advice.

This article clarifies mechanistic and practical boundaries beyond the scope of Cy5-5-NHS-Ester.com by providing direct quantitative benchmarks and updated recommendations for storage and elution practices.